1,291
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Effect of chromogranin A N-terminal fragment vasostatin-1 nano-carrier transfection on abdominal aortic aneurysm formation

, , , &
Pages 11018-11029 | Received 30 Aug 2021, Accepted 05 Nov 2021, Published online: 29 Nov 2021

References

  • Sakalihasan, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365(9470):1577–1589.
  • Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2019;16(4):225–242.
  • Davis FM, Rateri DL. Daugherty Abdominal aortic aneurysm: novel mechanisms and therapies. Curr Opin Cardiol. 2015;30(6):566–573.
  • Corsello A, Di Filippo L, Massironi S, et al. Vasostatin-1: a novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms. PLoS One. 2018;13(5):e0196858.
  • Yan C, Quan X-J, Feng Y-M. Nanomedicine for gene delivery for the treatment of cardiovascular diseases. Curr Gene Ther. 2019;19(1):20–30.
  • Yang F, Qin Y, Wang Y, et al. Metformin inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy. Int J Biol Sci. 2019;15(5):1010–1019.
  • Liu Q, Shan P, Li H. Gambogic acid prevents angiotensin IIinduced abdominal aortic aneurysm through inflammatory and oxidative stress dependent targeting the PI3K/Akt/mTOR and NFkappaB SPs. Mol Med Rep. 2019;19(2):1396–1402.
  • Varshney A, Panda JJ, Singh AK, et al. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Hepatology. 2018;67(4):1392–1407.
  • Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132(21):4653–4662.
  • Ravi Kumar MN, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 2004;25(10):1771–1777.
  • Zhang Q, Jiang Q, Fu Y, et al. The improvement of methods of establishing rat model of abdominal aortic aneurysm by pressure perfusion of eastase [J]. Chin J General Surg. 2013;022(12):1574–1579.
  • Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28–51.
  • Wang F, Wang X, Gao L, et al. Nanoparticle-mediated delivery of siRNA into zebrafish heart: a cell-level investigation on the biodistribution and gene silencing effects. Nanoscale. 2019;11(39):18052–18064.
  • Kim JH, Moon MJ, Kim DY, et al. Hyaluronic acid-based nanomaterials for cancer therapy. Polymers (Basel). 2018;10(10):1–8.
  • Sato Y, Watanabe R, Uchiyama N, et al. Inhibitory effects of vasostatin-1 against atherogenesis. Clin Sci (Lond). 2018;132(23):2493–2507.
  • Toghill BJ, Saratzis A, Bown MJ. Abdominal aortic aneurysm-an independent disease to atherosclerosis? Cardiovasc Pathol. 2017;27:71–75.
  • Giovinazzo F, Schimmack S, Svejda B, et al. CHGA and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation. PLoS One. 2013;8(11):e81111.